NCT01729728View on ClinicalTrials.gov

Pharmacokinetic, Efficacy and Safety Study of Tapentadol Oral Solution in Children With Postoperative Pain

PHASE2CompletedINTERVENTIONAL

Enrollment

86

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Postoperative PainAcute Pain

Interventions

DRUG

Tapentadol

Tapentadol oral solution single dose (1mg/kg body weight)

Trial Locations (1)

84124

Jean Brown Research, Salt Lake City

Sponsors

Lead Sponsor

Grünenthal GmbH

All Listed Sponsors

collaborator

Janssen Research & Development, LLC

INDUSTRY

lead

Grünenthal GmbH

INDUSTRY